Abstract
Vaginal cancer is infrequent, but the morbidity associated with treatment is high. Delays in diagnosis account for presentations in advanced stages. Screening is probably not warranted given the low incidence, but inspection of the vagina should be performed at the time of Pap smear screening. No molecular markers are currently promising. Chemoprevention with retinoids may be feasible.
Original language | English (US) |
---|---|
Pages (from-to) | 325-345 |
Number of pages | 21 |
Journal | Obstetrics and Gynecology Clinics of North America |
Volume | 23 |
Issue number | 2 |
State | Published - 1996 |
ASJC Scopus subject areas
- Obstetrics and Gynecology